<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR253">
 <label>253.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>ACY</given-names>
   </name>
   <name>
    <surname>To</surname>
    <given-names>KKW</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>AJX</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>RR</given-names>
   </name>
   <name>
    <surname>Hung</surname>
    <given-names>IFN</given-names>
   </name>
   <name>
    <surname>Kao</surname>
    <given-names>RYT</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>KH</given-names>
   </name>
   <name>
    <surname>Yuen</surname>
    <given-names>KY</given-names>
   </name>
  </person-group>
  <article-title>Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice</article-title>
  <source>Arch Virol</source>
  <year>2018</year>
  <volume>163</volume>
  <fpage>2349</fpage>
  <lpage>2358</lpage>
  <?supplied-pmid 29736671?>
  <pub-id pub-id-type="pmid">29736671</pub-id>
 </element-citation>
</ref>
